{"title":"Neutrophils in Inflammatory Bone Diseases.","authors":"Carmelo Carmona-Rivera, Mariana J Kaplan, Liam J O'Neil","doi":"10.1007/s11914-024-00865-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>In this review, we summarize the current evidence that suggests that neutrophils play a key role in facilitating damage to local bone structures.</p><p><strong>Recent findings: </strong>Neutrophil infiltration is a hallmark of inflammatory bone diseases such as rheumatoid arthritis (RA) and periodontitis disease (PD). Both of these human diseases are marked by an imbalance in bone homeostasis, favoring the degradation of local bone which ultimately leads to erosions. Osteoclasts, a multinucleated resident bone cell, are responsible for facilitating the turnover of bone and the bone damage observed in these diseases. The involvement of neutrophils and neutrophil extracellular trap formation have recently been implicated in exacerbating osteoclast function through direct and indirect mechanisms. We highlight a recent finding that NET proteins such as histones and elastase can generate non-canonical, inflammatory osteoclasts, and this process is mediated by post-translational modifications such as citrullination and carbamylation, both of which act as autoantigens in RA. It appears that NETs, autoantibodies, modified proteins, cytokines, and osteoclasts all ultimately contribute to local and permanent bone damage in RA and PD. However, more studies are needed to fully understand the role of neutrophils in inflammatory bone diseases.</p>","PeriodicalId":48750,"journal":{"name":"Current Osteoporosis Reports","volume":" ","pages":"280-289"},"PeriodicalIF":4.3000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11061041/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Osteoporosis Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11914-024-00865-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: In this review, we summarize the current evidence that suggests that neutrophils play a key role in facilitating damage to local bone structures.
Recent findings: Neutrophil infiltration is a hallmark of inflammatory bone diseases such as rheumatoid arthritis (RA) and periodontitis disease (PD). Both of these human diseases are marked by an imbalance in bone homeostasis, favoring the degradation of local bone which ultimately leads to erosions. Osteoclasts, a multinucleated resident bone cell, are responsible for facilitating the turnover of bone and the bone damage observed in these diseases. The involvement of neutrophils and neutrophil extracellular trap formation have recently been implicated in exacerbating osteoclast function through direct and indirect mechanisms. We highlight a recent finding that NET proteins such as histones and elastase can generate non-canonical, inflammatory osteoclasts, and this process is mediated by post-translational modifications such as citrullination and carbamylation, both of which act as autoantigens in RA. It appears that NETs, autoantibodies, modified proteins, cytokines, and osteoclasts all ultimately contribute to local and permanent bone damage in RA and PD. However, more studies are needed to fully understand the role of neutrophils in inflammatory bone diseases.
综述的目的:在这篇综述中,我们总结了目前的证据,这些证据表明中性粒细胞在促进局部骨结构损伤方面发挥着关键作用:中性粒细胞浸润是类风湿性关节炎(RA)和牙周炎(PD)等炎症性骨病的标志。这两种人类疾病的特点都是骨平衡失调,有利于局部骨质的降解,最终导致侵蚀。破骨细胞是一种多核常住骨细胞,负责促进这些疾病中观察到的骨转换和骨损伤。中性粒细胞的参与和中性粒细胞胞外捕获物的形成最近被认为通过直接和间接机制加剧了破骨细胞的功能。我们着重介绍了最近的一项发现,即组蛋白和弹性蛋白酶等NET蛋白可产生非典型、炎症性破骨细胞,而这一过程是由瓜氨酸化和氨甲酰化等翻译后修饰介导的,这两种修饰在RA中都是自身抗原。看来,NET、自身抗体、修饰蛋白、细胞因子和破骨细胞最终都会造成 RA 和 PD 的局部和永久性骨损伤。然而,要全面了解中性粒细胞在炎症性骨病中的作用,还需要进行更多的研究。
期刊介绍:
This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of osteoporosis.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as current and future therapeutics, epidemiology and pathophysiology, and evaluation and management. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.